» Articles » PMID: 39912974

Comprehensive Insights and In Silico Analysis into the Emerging Role of LincRNAs in Lung Diseases Pathogenesis; a Step Toward NcRNA Precision

Overview
Publisher Springer
Date 2025 Feb 6
PMID 39912974
Authors
Affiliations
Soon will be listed here.
Abstract

Long non-coding RNAs (lncRNAs) have emerged as essential regulators of gene expression, significantly influencing various biological processes. Approximately half of all lncRNAs are classified as long intergenic non-coding RNAs (lincRNAs), which are situated among coding genes. Recent studies have documented the role of lincRNAs in the pathogenesis of lung diseases, including lung cancer, pulmonary fibrosis, and pulmonary arterial hypertension. These lincRNAs can modulate gene expression through various mechanisms, including epigenetic modifications, transcriptional regulation, and post-transcriptional regulation. By functioning as competing endogenous RNAs (ceRNAs), lincRNAs can affect the activity of microRNAs (miRNAs) and their corresponding target genes. This review delves into the intricate mechanisms by which lincRNAs contribute to the development and progression of various lung diseases. Furthermore, it discusses the potential of lincRNAs as therapeutic targets.

References
1.
Wahlestedt C . Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013; 12(6):433-46. DOI: 10.1038/nrd4018. View

2.
Wu L, Liu C, Zhang Z . Knockdown of lncRNA MIAT inhibits proliferation and cisplatin resistance in non-small cell lung cancer cells by increasing miR-184 expression. Oncol Lett. 2020; 19(1):533-541. PMC: 6924112. DOI: 10.3892/ol.2019.11084. View

3.
Tontonoz P, Wu X, Jones M, Zhang Z, Salisbury D, Sallam T . Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia. Circulation. 2017; 136(8):776-778. PMC: 5657526. DOI: 10.1161/CIRCULATIONAHA.117.029002. View

4.
Qi P, Du X . The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2012; 26(2):155-65. DOI: 10.1038/modpathol.2012.160. View

5.
Eissa S, Swellam M, el-Mosallamy H, Mourad M, Hamdy N, Kamel K . Diagnostic value of urinary molecular markers in bladder cancer. Anticancer Res. 2003; 23(5b):4347-55. View